Emotional disturbances, social outcome and neurocognitive function in advanced melanoma survivors treated with pembrolizumab

Rogiers, A. I. (Speaker)

Activiteit: Talk or presentation at a conference

Periode28 nov 2018
EvenementstitelImmunotherapy Bridge 2018
EvenementstypeConference